Search research articles
Contact Us
Filters
Showing results (121-130 of 1,137) with videos related to
Page
of 114
Sort By:
Current Opinion in Lipidology
|
November 11, 2006
The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy
Stephen D Wiviott, Christopher P Cannon
The Journal of the Oklahoma State Medical Association
|
February 1, 1980
Early and late results of duodenal ulcer disease treated by vagotomy-pyloroplasty and vagotomy-antrectomy
M A Jacocks, J P Cannon
The American Journal of Cardiology
|
November 15, 1996
Cardiovascular risk stratification of pulmonary embolism
C P Cannon, S Z Goldhaber
Future Cardiology
|
October 7, 2009
A point-of-care assay to measure platelet aggregation in patients taking clopidogrel
Dalton S McLean, Christopher P Cannon
Critical Pathways in Cardiology
|
March 15, 2008
How to join a clinical trial
Ellis W Lader, Christopher P Cannon
Critical Pathways in Cardiology
|
March 15, 2008
Time to benefit: an emerging concept for assessing the efficacy of statin therapy in cardiovascular disease
Kausik K Ray, Christopher P Cannon
The American Journal of Managed Care
|
April 27, 2011
New options for stroke prevention in atrial fibrillation
Christopher P Cannon, Eric C Stecker
Journal of the American College of Cardiology
|
December 14, 2011
Personalized therapy following drug-eluting stenting using platelet function testing and C-reactive protein
Grant W Reed, Christopher P Cannon
American Heart Journal
|
February 5, 2004
Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT
Eli V Gelfand, Christopher P Cannon
Reviews in Cardiovascular Medicine
|
July 5, 2012
Atherosclerosis. Effects of evacetrapib administered as monotherapy or in combination with statins
Dylan L Steen, Christopher P Cannon
Page
of 114
Search research articles
Search
Showing results (121-130 of 1,137) with videos related to
Sort By:
Page
of 114
Current Opinion in Lipidology
|
November 11, 2006
The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy
Stephen D Wiviott, Christopher P Cannon
The Journal of the Oklahoma State Medical Association
|
February 1, 1980
Early and late results of duodenal ulcer disease treated by vagotomy-pyloroplasty and vagotomy-antrectomy
M A Jacocks, J P Cannon
The American Journal of Cardiology
|
November 15, 1996
Cardiovascular risk stratification of pulmonary embolism
C P Cannon, S Z Goldhaber
Future Cardiology
|
October 7, 2009
A point-of-care assay to measure platelet aggregation in patients taking clopidogrel
Dalton S McLean, Christopher P Cannon
Critical Pathways in Cardiology
|
March 15, 2008
How to join a clinical trial
Ellis W Lader, Christopher P Cannon
Critical Pathways in Cardiology
|
March 15, 2008
Time to benefit: an emerging concept for assessing the efficacy of statin therapy in cardiovascular disease
Kausik K Ray, Christopher P Cannon
The American Journal of Managed Care
|
April 27, 2011
New options for stroke prevention in atrial fibrillation
Christopher P Cannon, Eric C Stecker
Journal of the American College of Cardiology
|
December 14, 2011
Personalized therapy following drug-eluting stenting using platelet function testing and C-reactive protein
Grant W Reed, Christopher P Cannon
American Heart Journal
|
February 5, 2004
Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT
Eli V Gelfand, Christopher P Cannon
Reviews in Cardiovascular Medicine
|
July 5, 2012
Atherosclerosis. Effects of evacetrapib administered as monotherapy or in combination with statins
Dylan L Steen, Christopher P Cannon
Page
of 114